Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Terminated 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 5Interventional 3

Sponsor

Cancer Type

Endocrine 3Genitourinary 1

Conditions

Adrenal Gland Neoplasms 2Urinary Bladder Neoplasms 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1Carcinoma, Renal Cell 1Adrenocortical Adenoma 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Adrenalectomy × Clear all
NCT07470580 2026-03-13

ADERADHTA2

University Hospital, Toulouse

Phase NA Not yet recruiting
134 enrolled
Endocrine

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT01246739 2024-04-10

AUSC

Region Skane

Phase NA Terminated
34 enrolled
Endocrine

Adrenal Gland Neoplasms

NCT04570176 2022-02-16

Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System

The Affiliated Hospital of Qingdao University

Phase NA Completed
1 enrolled
EndocrineGenitourinary

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡